May 10 (SeeNews) - North Macedonia-based drug maker Replek [MSE:REPL] said its shareholders have approved a plan to carry out a 1 to 10 stock split without changing the company's capital.
Each of the company's regular shares with a nominal value of 562.42 euro ($606.4) per share will be split into ten shares with a nominal value of 56.242 euro per share, the company said in a filing to the Skopje bourse last month.
Currently, its share capital totals 14.577 million euro and is distributed in 25,920 shares with a nominal value of 562.42 euro.
Following the stock split, the company's capital will be distributed into 259,200 shares with a nominal value of 56.242 euro.
Replek's shares last traded at an average price of 112,750 denars on the Macedonian Stock Exchange (MSE) on Thursday, according to the latest available bourse data.
($ = 0.928 euro)